ViiV posts positive long-term data for two-drug HIV regimen Dovato
GlaxoSmithKline subsidiary ViiV Healthcare has reported three-year data for its two-drug HIV regimen Dovato, with hopes that the long-term data could encourage clini...
Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.
Continue readingExploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.
Continue readingExploring emerging approaches to neurodegenerative disease research and treatment.
Continue readingHighlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
Advertisement